(Q40946036)

25 September 2017

Suppressive activity of mefloquine in sporozoite-induced human malaria (English)

1 reference

25 September 2017

0 references

1 reference

Clyde DF

1

1 reference

25 September 2017

McCarthy VC

series ordinal

2

1 reference

25 September 2017

Miller RM

series ordinal

3

1 reference

25 September 2017

Hornick RB

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 March 1976

1 reference

Antimicrobial Agents and Chemotherapy

25 September 2017

1 reference

25 September 2017

9

1 reference

25 September 2017

3

1 reference

25 September 2017

384-386

1 reference

Clinical testing of new antimalarial compounds

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429540

Mefloquine (WR 142,490) in the Treatment of Human Malaria

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429540

Treatment of falciparum malaria caused by strain resistant to quinine

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429540

Infections with Plasmodium falciparum and Plasmodium vivax in the owl monkey--model systems for basic biological and chemotherapeutic studies

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=429540

19 August 2018

Identifiers

DOI

10.1128/AAC.9.3.384

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

769678

1 reference